BioStem Technologies, Inc.

OTC: BSEM · Healthcare · Biotechnology

PublicHQ Fort Lauderdale, FL · BrowardCIK 0001658678Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 55

v0.1 · 5/100 weight · pillars only

↑ Altman-Z, market scale · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

-$18.9M

Rev growth YoY (TTM)

-105.7%

Net income (FY)

—

Employees

—

Market cap

$55.0M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

BioStem Technologies, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Fractyl Health, Inc.28D DocGo Inc.44D Acrivon Therapeutics, Inc. Common Stock——Boundless Bio, Inc.——

Neighbors

Broward →

HEICO Corporation$4.5B84B+Element Solutions Inc$2.6B78B+Chewy, Inc.$12.6B58C VSE Corporation$1.1B68B AutoNation, Inc.$27.6B74B National Beverage Corp.$1.2B78B+

Key facts

CEOJason Matuszewski

SectorHealthcare

IndustryBiotechnology

HeadquartersFort Lauderdale, FL

ExchangeOTC: BSEM

Employees—

IPO date2015-03-17

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.